Burning Rock Biotech Limited Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Burning Rock Biotech Limited (BNR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.61% for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2024-04-29
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|
| 2023-12-31 | 4.61% 20-F · filed 2024-04-29 |
| 2022-12-31 | 3.94% 20-F · filed 2024-04-29 |
| 2021-12-31 | 2.07% 20-F · filed 2024-04-29 |
| 2020-12-31 | 1.90% 20-F · filed 2023-04-20 |
| 2019-12-31 | 2.41% 20-F · filed 2022-04-29 |
| 2018-12-31 | 3.05% 20-F · filed 2021-03-23 |